Checkpoint Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
24 May 2024	Form 3: Fortress Biotech, Inc., 10% owner Holds 3,589,193 shares of COMMON STOCK, PAR VALUE $0.0001
19 Mar 2024	Form 3: Amit Sharma, Director Holds 50,000 shares of Common Stock (Restricted)
19 Oct 2018	Form 3: Bechon Christian, Director Holds 50,000 shares of Common Stock (Restricted)
07 Jun 2017	Form 3: Fortress Biotech, Inc., 10% owner Holds 1,981,006 shares of Common Stock, $0.0001 par value
22 Dec 2016	Form 3: Gray William Garrett, See Remarks Holds 30,000 shares of Common Stock (Restricted)
04 Oct 2016	Form 3: Horin David J, Interim CFO Holds 0 shares of Common Stock (Restricted)
04 Oct 2016	Form 3: Salzman Barry M, Director Holds 50,000 shares of Common Stock (Restricted)
04 Oct 2016	Form 3: Herskowitz Neil, Director Holds 0 shares of Common Stock (Restricted)
04 Oct 2016	Form 3: Oliviero James F Iii, CEO and President Holds 1,000,000 shares of Common Stock (Restricted)
04 Oct 2016	Form 3: Weiss Michael S, Director Holds 0 shares of Common Stock (Restricted)
04 Oct 2016	Form 3: Boilen Scott, Director Holds 50,000 shares of Common Stock (Restricted)
04 Oct 2016	Form 3: Rosenwald Lindsay A Md, Director Holds 0 shares of Common Stock (Restricted)

Comments